tiprankstipranks
Advertisement
Advertisement

LXRX Stock Latest News

Lexicon to present data at AAN annual meeting on Progress Phase 2b study
The FlyLexicon to present data at AAN annual meeting on Progress Phase 2b study
2d ago
LXRX
Lexicon COGT reports Q1 EPS $2.07, consensus $1.74
PremiumThe Fly
Lexicon COGT reports Q1 EPS $2.07, consensus $1.74
2d ago
LXRX
Lexicon, Novo Nordisk announce initiation of LX9851 study
PremiumThe Fly
Lexicon, Novo Nordisk announce initiation of LX9851 study
27d ago
NVO
LXRX
Lexicon announces results from post hoc analysis on data of sotagliflozin
PremiumThe Fly
Lexicon announces results from post hoc analysis on data of sotagliflozin
1M ago
LXRX
Lexicon price target raised to $2.30 from $2.10 at Citi
PremiumThe Fly
Lexicon price target raised to $2.30 from $2.10 at Citi
1M ago
LXRX
Lexicon Pharmaceuticals Signals Leaner Path to Key Milestones
PremiumCompany AnnouncementsLexicon Pharmaceuticals Signals Leaner Path to Key Milestones
1M ago
LXRX
Lexicon price target raised to $6 from $4 at H.C. Wainwright
Premium
The Fly
Lexicon price target raised to $6 from $4 at H.C. Wainwright
1M ago
LXRX
Lexicon reports Q4 EPS (4c), consensus (7c)
Premium
The Fly
Lexicon reports Q4 EPS (4c), consensus (7c)
1M ago
LXRX
LXRX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
LXRX Earnings this Week: How Will it Perform?
2M ago
LXRX
Lexicon Pharmaceuticals Bolsters Capital Through Equity Financing
PremiumCompany Announcements
Lexicon Pharmaceuticals Bolsters Capital Through Equity Financing
3M ago
8K
LXRX
Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
PremiumThe Fly
Midday Fly By: Warsh nominated for Fed chair, Apple reports Q1 beat
3M ago
V
CL
Lexicon 32M share Spot Secondary priced at $1.30
PremiumThe Fly
Lexicon 32M share Spot Secondary priced at $1.30
3M ago
LXRX
Lexicon Pharmaceuticals Launches Equity Offering to Fund Pipeline
PremiumCompany AnnouncementsLexicon Pharmaceuticals Launches Equity Offering to Fund Pipeline
3M ago
8K
LXRX
Lexicon announces common stock offering, no amount given
Premium
The Fly
Lexicon announces common stock offering, no amount given
3M ago
LXRX
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
Premium
The Fly
Midday Fly By: Netflix reports Q4 beat, Smithfield to acquire Nathan’s
3M ago
DB
ANF
Lexicon completes End-of-Phase 2 meeting with U.S. FDA for pilavapadin
PremiumThe Fly
Lexicon completes End-of-Phase 2 meeting with U.S. FDA for pilavapadin
3M ago
LXRX
Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target
PremiumRatings
Lexicon Pharmaceuticals: Global INPEFA Expansion and Late-Stage Pipeline Catalysts Support Buy Rating and $4 Target
3M ago
LXRX
Lexicon Pharmaceuticals: Late-Stage Pipeline Catalysts and Strategic Partnerships Underpin Buy Rating
PremiumRatings
Lexicon Pharmaceuticals: Late-Stage Pipeline Catalysts and Strategic Partnerships Underpin Buy Rating
3M ago
LXRX
Lexicon price target raised to $2.10 from $1.90 at Citi
PremiumThe Fly
Lexicon price target raised to $2.10 from $1.90 at Citi
3M ago
LXRX
Lexicon sees cash runway into 2027
PremiumThe FlyLexicon sees cash runway into 2027
3M ago
LXRX
Lexicon publishes White Paper on treatments for chronic pain
Premium
The Fly
Lexicon publishes White Paper on treatments for chronic pain
3M ago
LXRX
Lexicon Pharmaceuticals: Buy Rating Backed by Promising Cardiovascular and Neuropathic Pain Advances
Premium
Ratings
Lexicon Pharmaceuticals: Buy Rating Backed by Promising Cardiovascular and Neuropathic Pain Advances
4M ago
LXRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >